Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 500,000 shares at $8.00 ($2.0M) on 2021-09-20, disclosed to the SEC on 2021-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 250,000 | $0 | 0.0% |
| 2 | $8.00 | 250,000 | $2.0M | 100.0% |
| Total | $4.00 avg | 500,000 | $2.0M | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-05-20 | $199K | — | Filing → |